Skip to content

BIONCISE: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BIONCISE

BE 0671.983.435
NACE 32.500, Manufacture of medical and dental instruments and supplies
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€29,476
2024 · €26,767-€56,243
Equity
€172,478
2024 · €201,954-€29,476
Cash
€68,841
2024 · €41,389+€27,452
Balance sheet total
€242,768
2024 · €266,464-€23,696

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€28,488

    down €28,488 (-34.6%), from €82,407 to €53,919

    of which Plant, machinery and equipment: -€30,729

  • Cash +€27,452

    up €27,452 (+66.3%), from €41,389 to €68,841

    mainly Depreciation (+€33,864) and Receivables within one year (+€21,254)

  • Receivables within one year -€21,254

    down €21,254 (-18.9%), from €112,240 to €90,986

    of which Trade receivables: -€22,300

  • Stocks and contracts -€11,407

    down €11,407 (-37.5%), from €30,428 to €19,021

  • Deferred charges and accrued income +€10,001

    new in 2025: €10,001

Equity and liabilities
  • Profit (loss) carried forward -€29,476

    down €29,476 (-25.0%), from -€118,046 to -€147,522

  • Other debts +€9,432

    up €9,432 (+33.9%), from €27,795 to €37,227

  • Trade debts -€5,689

    down €5,689 (-25.5%), from €22,349 to €16,660

Income statement
  • Gross operating margin -€38,512

    down €38,512 (-23.5%), from €163,961 to €125,449

  • Staff costs +€32,265

    up €32,265 (+37.7%), from €85,510 to €117,775

  • Other operating charges -€5,390

    down €5,390 (-61.0%), from €8,836 to €3,446

  • Financial charges -€3,898

    down €3,898 (-53.6%), from €7,268 to €3,370

  • Financial income +€2,859

    up €2,859 (+426.1%), from €671 to €3,530

    of which Non-recurring financial income: +€2,465

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €26,767
Gross operating margin -€38,512
Staff costs -€32,265
Depreciation +€2,387
Other operating charges +€5,390
Financial income +€2,859
Financial charges +€3,898
Result 2025 -€29,476

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€31,732
Investment -€5,376
Financing +€1,096
Cash 2024 €41,389
Net result for the year -€29,476
Depreciation +€33,864
Stocks and contracts +€11,407
Receivables within one year +€21,254
Deferred charges and accrued income -€10,001
Trade debts -€5,689
Tax, wage and social debts +€941
Other debts +€9,432
Investment in fixed assets (net) -€5,376
Debts after one year +€1,097
Short-term financial debts -€1
Cash 2025 €68,841
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €266,464 €242,768 -€23,696 -8.9%
Fixed assets 21/28 €82,407 €53,919 -€28,488 -34.6%
Tangible fixed assets 22/27 €82,407 €53,919 -€28,488 -34.6%
Plant, machinery and equipment 23 €78,084 €47,355 -€30,729 -39.4%
Furniture and vehicles 24 €4,323 €6,564 +€2,241 +51.8%
Current assets 29/58 €184,057 €188,849 +€4,792 +2.6%
Stocks and contracts in progress 3 €30,428 €19,021 -€11,407 -37.5%
Stocks 30/36 €30,428 €19,021 -€11,407 -37.5%
Amounts receivable within one year 40/41 €112,240 €90,986 -€21,254 -18.9%
Trade receivables 40 €78,035 €55,735 -€22,300 -28.6%
Other amounts receivable 41 €34,205 €35,251 +€1,046 +3.1%
Cash at bank and in hand 54/58 €41,389 €68,841 +€27,452 +66.3%
Deferred charges and accrued income 490/1 - €10,001 +€10,001
Total equity and liabilities 10/49 €266,464 €242,768 -€23,696 -8.9%
Equity 10/15 €201,954 €172,478 -€29,476 -14.6%
Contributions 10/11 €320,000 €320,000 = 0.0%
Capital 10 €320,000 €320,000 = 0.0%
Issued capital 100 €320,000 €320,000 = 0.0%
Profit (loss) carried forward 14 -€118,046 -€147,522 -€29,476 -25.0%
Amounts payable 17/49 €64,510 €70,290 +€5,780 +9.0%
Amounts payable after more than one year 17 €2,114 €3,211 +€1,097 +51.9%
Financial debts 170/4 €2,114 €3,211 +€1,097 +51.9%
Amounts payable within one year 42/48 €62,396 €67,079 +€4,683 +7.5%
Financial debts 43 €4,059 €4,058 -€1 0.0%
Credit institutions 430/8 €4,059 €4,058 -€1 0.0%
Trade debts 44 €22,349 €16,660 -€5,689 -25.5%
Suppliers 440/4 €22,349 €16,660 -€5,689 -25.5%
Taxes, remuneration and social security 45 €8,193 €9,134 +€941 +11.5%
Remuneration and social security 454/9 €8,193 €9,134 +€941 +11.5%
Other amounts payable 47/48 €27,795 €37,227 +€9,432 +33.9%
Remuneration, social security and pensions 62 €85,510 €117,775 +€32,265 +37.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €36,251 €33,864 -€2,387 -6.6%
Other operating charges 640/8 €8,836 €3,446 -€5,390 -61.0%
Gross operating margin 9900 €163,961 €125,449 -€38,512 -23.5%
Operating profit (loss) 9901 €33,364 -€29,636 -€63,000
Financial income 75/76B €671 €3,530 +€2,859 +426.1%
Recurring financial income 75 €671 €1,065 +€394 +58.7%
Non-recurring financial income 76B - €2,465 +€2,465
Financial charges 65/66B €7,268 €3,370 -€3,898 -53.6%
Recurring financial charges 65 €7,268 €3,370 -€3,898 -53.6%
Profit (loss) for the period before taxes 9903 €26,767 -€29,476 -€56,243
Profit (loss) for the period 9904 €26,767 -€29,476 -€56,243
Profit (loss) for the period to be appropriated 9905 €26,767 -€29,476 -€56,243

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.